Tops & Flops Stocks
Security ▲ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Syndax Pharmaceuticals Inc | -0.520% | -9.048% | -6.373% | -1.546% | 2.139% | 30.822% | - |
Synergy Pharmaceuticals | - | - | - | - | - | - | - |
Synthetic Biologics Inc. | 0.290% | -0.566% | -15.301% | -45.923% | -12.125% | -91.938% | -93.240% |
Syros Pharmaceuticals Inc. | -2.140% | - | 17.991% | 34.309% | -23.485% | -88.925% | - |
Sysmex Corp. | -2.520% | 1.307% | 13.139% | -75.781% | -68.238% | -80.864% | -74.878% |
T2 Biosystems Inc. | -44.060% | - | - | - | - | - | - |
Tabula Rasa HealthCare Inc | -1.520% | - | - | - | - | - | - |
Tactile Systems Technology Inc | - | -1.600% | -4.651% | -34.921% | -4.651% | -71.789% | - |
Takara Bio Inc. | 0.820% | 3.361% | 11.818% | -41.981% | -20.130% | -72.045% | -66.033% |
Takeda Pharmaceutical Co Ltd | -0.900% | -2.132% | -1.338% | -18.520% | -6.243% | -15.079% | -25.505% |
TALI Digital Ltd. | -50.000% | 0.000% | -50.000% | 0.000% | 0.000% | -96.774% | -91.667% |
Tandem Diabetes Care Inc | 5.430% | 11.613% | 56.435% | 74.578% | 63.525% | -35.408% | - |
TapImmune Inc | - | - | - | - | - | - | - |
Taro Pharmaceutical Industries Ltd | 1.030% | 0.513% | -0.508% | 46.269% | 4.255% | -31.826% | -56.401% |
Teladoc Health Inc | 1.820% | -7.460% | -10.619% | -50.513% | -45.445% | -90.557% | - |
Teleflex Inc. | -0.990% | 2.538% | 4.124% | -11.404% | -10.619% | -37.267% | - |
Teligent Inc. | 725.000% | - | - | - | - | - | - |
Tenax Therapeutics Inc. | - | - | - | - | - | - | - |
Tenet Healthcare | 0.000% | 3.419% | 38.286% | 79.259% | 75.362% | 138.753% | 547.059% |
Terumo Corp. | -3.050% | 0.000% | 3.205% | -42.500% | -45.238% | -46.333% | - |
Tesaro Inc. | - | - | - | - | - | - | - |
Tetraphase Pharmaceuticals | -10.670% | - | - | - | - | - | - |
Teva Pharmaceutical Industries Ltd ADR | 2.290% | -3.165% | 26.446% | 109.016% | 64.163% | 69.061% | 43.662% |
TG Therapeutics Inc. | 2.420% | -7.878% | 18.134% | -44.800% | -4.757% | -43.868% | - |
THC Biomed International Inc. | - | - | - | - | - | - | - |